ClinicalTrials.gg
Not yet recruitingNCT07914517SSC VAS HPAUpdated Nov 5, 2026

The Effect of Skin-to-Skin Contact on Pain and Anxiety During Episiotomy Repair

An interventional study of Skin-to-skin contact during episiotomy repair in Episiotomy and Pain, sponsored by Adiyaman University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 49 Years. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Adiyaman University · Not applicable, Interventional, and Supportive care

Updated Nov 5, 2026Study contact changedNewly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
126
Allocation
Randomized
Ages
18 Years to 49 Years
Sex
Female
01

Study summary

Episiotomy is a surgical incision made in the perineum during the second stage of labor. The suturing (repair) process following episiotomy causes significant acute perineal pain and state anxiety in women due to the rich nerve supply of the perineum. Although the physiological and psychological benefits of early skin-to-skin contact (SSC) for mothers and newborns are widely reported in the literature, studies evaluating the effects of SSC on maternal pain and anxiety during episiotomy repair, when surgical stress is intense, are limited.

The aim of this study is to investigate the effects of early skin-to-skin contact during episiotomy repair on women's pain and state anxiety levels and to compare the group receiving SSC with the group receiving standard routine care. The study will be conducted as a randomized controlled experimental study, and the sample size has been calculated using power analysis. The data collection tools will include the Descriptive Information Form, Visual Analog Scale (VAS), and Spielberger State Anxiety Inventory.

SSC applied during repair stimulates endogenous oxytocin release, reduces hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system activity, supports the parasympathetic system, and provides natural analgesic and anxiolytic effects. It also shifts the mother's attention from the pain of the surgical procedure to her baby. Conducted within the framework of woman-centered midwifery care, this study aims to address the gap in the literature regarding the analgesic and anxiolytic effects of SSC during episiotomy repair and to contribute evidence-based knowledge to clinical midwifery practice.

Read the detailed description

This study is a randomized controlled experimental study. Its aim is to determine the effects of skin-to-skin contact during episiotomy repair on mothers' pain and anxiety levels.

The study will be conducted in the Labor and Delivery Unit of Adıyaman Maternity and Children's Hospital. Data will be collected between November 1, 2026, and March 1, 2027. The unit operates on a shift system, with eight midwives working during daytime hours and six midwives providing shift services. The hospital also has 11 obstetricians and six resident physicians. The labor and delivery unit has a capacity of 21 patients and includes 21 labor and delivery rooms. Normal vaginal births are performed in this unit, which also provides postpartum care for mothers and newborns.

The study population consists of women who give birth vaginally and undergo episiotomy in the hospital's Labor and Delivery Unit. An a priori power analysis was performed using G*Power 3.1.9.2. An effect size of 0.58, statistical power of 95%, and a type I error level of 0.05 were accepted. Based on the assumption of a 10-point reduction in the mean anxiety score, the required sample size was calculated as 126 women, with at least 63 women in each group. The effect size was based on the mean anxiety scores and standard deviations reported in the study by Şolt Kırca and Kanza Gül. Eligible women who voluntarily agree to participate will be included in the study and randomly assigned to the skin-to-skin contact group or the control group using simple randomization.

The inclusion criteria are being able to speak and understand Turkish, being 18-49 years of age, having a spontaneous vaginal birth with mediolateral episiotomy, having no signs of infection such as redness or swelling in the episiotomy area, and voluntarily agreeing to participate.

The exclusion criteria are conditions requiring more than 5 mL of 2% lidocaine during episiotomy repair, the presence of an infectious disease, deep tissue lacerations, vacuum-assisted birth, shoulder dystocia, an anxiety or anxiety-related problem, postpartum complications such as uterine atony, and psychiatric disorders that may affect pain or anxiety perception.

Women who meet the eligibility criteria will be listed according to birth order. Randomization will be performed using the Random Integer Generator in the Numbers section of the Random.org website. At the beginning of the study, a draw will determine which group is represented by the numbers 1 and 2. Women will then be randomly assigned to the skin-to-skin contact group or the control group according to the randomization list. Written informed consent will be obtained from women who agree to participate.

Data will be collected using a Descriptive Information Form, an Episiotomy Assessment Form, the Visual Analog Scale (VAS), and the Spielberger State Anxiety Inventory. The Descriptive Information Form will collect sociodemographic information, including age, education level, employment status, social security, income, and participation in childbirth preparation education. The Episiotomy Assessment Form will record characteristics of the episiotomy and repair process. A disposable paper measuring tape measuring 0-100 mm will be used to assess episiotomy dimensions, and a digital stopwatch will be used to measure repair duration, starting with the first suture and ending when the repair is completed.

The VAS will be used to assess pain intensity on a scale from 0 to 10, where 0 indicates no pain and 10 indicates the most severe pain imaginable. Higher scores indicate greater perceived pain. The Spielberger State Anxiety Inventory will be used to assess state anxiety at a particular time and under specific conditions. It consists of 20 items rated on a four-point Likert scale, with total scores ranging from 20 to 80. Higher scores indicate higher state anxiety levels.

The researcher will administer the personal information form through face-to-face interviews during the latent phase of labor in the hospital's labor and delivery room. Participants will be informed about the study's purpose and procedures, and written informed consent will be obtained before data collection. Immediately after episiotomy repair, characteristics of the episiotomy and suturing process will be recorded using the Episiotomy Assessment Form.

Pain and anxiety assessments will be performed at the following time points:

  • The first VAS measurement will be performed immediately before episiotomy repair.
  • The second VAS measurement will be performed five minutes after skin-to-skin contact begins, while suturing is still in progress.
  • The third VAS measurement and the Spielberger State Anxiety Inventory will be administered 60 minutes after episiotomy repair is completed.

In the skin-to-skin contact group, the intervention will begin after the internal suturing stage of episiotomy repair and continue throughout skin suturing. The newborn will be positioned to maintain direct skin contact with the mother. The safety of the mother and newborn will be monitored, including observation of the newborn's breathing, skin color, and muscle tone. Maternal comfort and appropriate positioning will be ensured. When clinically necessary, routine care and required medical interventions will take priority. Women in the control group will not receive the study-specific intervention, and VAS and anxiety assessments will be conducted at the same time points as in the skin-to-skin contact group.

The independent variable is skin-to-skin contact during episiotomy repair. The dependent variables are pain intensity and state anxiety during and after episiotomy repair. The study hypotheses are that skin-to-skin contact during episiotomy repair reduces women's pain levels and state anxiety levels.

Data will be analyzed using descriptive statistics, the Shapiro-Wilk test, Pearson's chi-square test, Fisher's exact test, the independent-samples t-test, the Mann-Whitney U test, mixed-design repeated-measures analysis of variance, and, where necessary, linear mixed-effects models. Appropriate group and time comparisons will be performed for state anxiety scores. Statistical significance will be set at p \< 0.05.

02

Conditions studied

  • Episiotomy
  • Pain

Keywords

  • skin-to-skin contact
  • episiotomy
  • pain
  • state anxiety
  • midwifery care
03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's planned enrollment of 126 is above the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Adiyaman University is the lead sponsor of 31 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being able to speak and understand Turkish.
  • Being 18-49 years of age.
  • Having a spontaneous vaginal birth with mediolateral episiotomy.
  • Having no signs of infection, such as redness or swelling, in the episiotomy area.
  • Voluntarily agreeing to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Conditions requiring more than 5 mL of 2% lidocaine during episiotomy repair.
  • Presence of an infectious disease.
  • Presence of deep tissue lacerations.
  • Vacuum-assisted birth.
  • Development of shoulder dystocia.
  • Presence of anxiety or an anxiety-related problem.
  • Development of postpartum complications, such as uterine atony.
  • Presence of a psychiatric disorder that may affect pain or anxiety perception.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
126 participants (estimated)

Study arms

  • Experimental
    SKİN-TO-SKİN CONTACT GROUP

    Skin-to-skin contact between the mother and newborn during episiotomy repair following vaginal birth

    Behavioral: Skin-to-skin contact during episiotomy repair

  • No intervention
    CONTROL GROUP

Interventions

  • BehavioralSkin-to-skin contact during episiotomy repair

    Skin-to-skin contact between the mother and newborn during episiotomy repair following vaginal birth

06

What researchers measure

Primary outcomes

  1. Pain Intensity During Episiotomy Repair

    Pain intensity will be assessed using the Visual Analog Scale (VAS), scored from 0 (no pain) to 10 (the most severe pain imaginable). Measurements will be performed immediately before episiotomy repair, five minutes after the start of skin-to-skin contact while suturing is ongoing, and 60 minutes after completion of episiotomy repair.

    Time frame: Immediately before episiotomy repair; 5 minutes after the start of skin-to-skin contact while suturing is ongoing; and 60 minutes after completion of episiotomy repair.

Secondary outcomes

  1. State Anxiety

    State anxiety will be assessed using the Spielberger State Anxiety Inventory, which consists of 20 items rated on a four-point Likert scale, with total scores ranging from 20 to 80. Higher scores indicate higher levels of state anxiety.

    Time frame: 60 minutes after completion of episiotomy repair.

07

Study locations

1 site
  • Adıyaman Kadın Doğum ve Çocuk Hastalıkları Hastanesi
    Adıyaman, Adıyaman Province, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Mar 2027, 4 months later.

Of 3,731 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 4 months is below that.

Counting every sponsor, half of 3,830 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 28, 2026
First posted
Nov 3, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Mar 1, 2027
CompletionEst.
Mar 1, 2027
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Contact
Study contact changed: t•••@gmail.com · •••7516→t•••@gmail.com · •••7516. See the current contact
Nov 5, 2026
Registered
First appeared on the registry
Nov 3, 2026
Show all 2 updates
  1. Nov 5, 2026
    Contact Study contact changed: t•••@gmail.com · •••7516→t•••@gmail.com · •••7516. See the current contact
    + 3 other changes: identifiers, verification date and responsible party
  2. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07914517
Lead sponsor
Adiyaman University
Responsible party
Elif Beyza Türen (Principal Investigator, Adiyaman University) — Principal investigator
First posted
Nov 3, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Mar 1, 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Nov 5, 2026

Study contacts

Elif Beyza Türen, MSc
Contact
trnelif135@gmail.com
+90 546 884 75 16

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion